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How the Fanconi anaemia (FA) chromosome stability pathway functions to cope 
with interstrand crosslinks and other DNA lesions has been elusive, even after 
FANCD1 proved to be BRCA2, a partner of Rad51 in homologous recombination. 
The identification and characterization of two new Fanconi proteins having 
helicase motifs, FANCM and FANCJ/BRIP1/BACH1, implicates the FANC nuclear 
core complex as a participant in recognizing or processing damaged DNA, and 
the BRIP1 helicase as acting independently of this complex.  
 Fanconi anaemia is a chromosome instability disorder characterized by diverse congenital 
abnormalities, retarded growth, early predisposition to cancer, and bone marrow failure. The 
hallmark of FA cells is their high sensitivity to chromosomal breakage and killing caused by 
exposure to DNA interstrand crosslinking agents (e.g. mitomycin C, cisplatin). This property has 
long suggested that a major biochemical defect underlying FA involves defective repair of these 
uniquely toxic lesions. The search for the mechanistic basis of FA proteins at the chromosomal 
level has been a protracted endeavor, with the first cloning of an FA gene (FANCC) in 1992 
when there were just four known complementation groups1. Since then, the count has climbed to 
11 groups representing distinct genes (FANCA/B/C/D1/D2/E/F/G/I/J/L)2. Remarkably, only one 
of the encoded proteins, FANCD1/BRCA23, is implicated directly in DNA repair (via 
homologous recombination, HR), and its functional relationship to other FANC proteins has 
been obscure. Now, two articles in this issue reveal the identity of FANCJ to be a previously 
discovered DNA unwinding enzyme (helicase) designated BACH1/BRIP14. Studies by Levitus 
et al.5 on page XXX, and by Levran et al.6 on page XXX, localized FANCJ to a region on 
chromosome 17q22, pursued BRIP1 as a likely candidate, and identified biallelic BRIP1 
mutations in FA patients. Extending this finding further in chicken DT40 cells, Bridge et al.7 
report on page XXX the characterization of a brip1 knockout mutant; they discover that its 
phenotype is essentially identical to that of a fancc mutant. Adding further excitement to the 
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helicase story, Meetei et al.8 (page XXX) used mass spectrometry to identify yet another new FA 
protein, FANCM/FAAP250, as a member of the FANC core complex that has homology with 
both helicases and endonucleases, in particular the dual-domain archaeal Hef protein. 
Concurrently, Mosedale et al. 9 provide insightful characterization of hef/fancm partial deletion 
mutants of DT40 cells. 
 
Linkage to DNA repair 
 
 We may now hold a critical missing link within the FANC pathway, i.e. two new enzymes 
that interact with DNA. BRIP1/BACH1 was first identified as an interactor with the BRCA1 
tumour suppressor4. BRIP1 was shown to be a 5′ to 3′ helicase, and germline mutations affecting 
the helicase function were detected in two early-onset breast cancer patients10. BRIP1, like 
BRCA1, was implicated in repairing double-strand breaks (DSBs) produced by ionizing 
radiation4. However, the normal X-ray sensitivity of the brip1 DT40 mutant argues against a role 
in such DSB repair7. Moreover, a truncated human BRIP1 cDNA lacking the C-terminal 
BRCA1-interacting region, fully corrected brip1 cells for sensitivity to cisplatin whereas a 
helicase-inactivating point mutation (Walker A-box K52R substitution) did not, implying that 
BRIP1’s helicase activity is essential for resistance to crosslinks. A brip1 fancc double mutant 
closely resembles the single mutants, further suggesting that BRIP1 acts within the same 
pathway as the FA core complex proteins. 
 Very recently, characterization of the substrate specificity of purified recombinant BRIP1 
showed that it preferentially binds and unwinds forked duplexes11. With model substrates that 
mimic the HR structure known as a D-loop, BRIP1 can also release the invading strand, even 
when it lacks a single-stranded tail. Unlike BLM helicase, which is curiously associated with 
FANC core complex proteins12, BRIP1 fails to unwind synthetic 4-way structures that model the 
classical Holliday junction11. 
 FANCM/FAAP250/Hef contains two potential enzymatic domains8. One is homologous to a 
superfamily of DEAH-box helicases or DNA-stimulated ATPases, and the other homologous to 
the endonuclease domain of XPF/ERCC4. However, the C-terminal endonuclease domain of 
FANCM has diverged from XPF and other nucleases to the extent it is expected to be 
nonfunctional. In contrast, FANCM’s helicase domains are highly conserved compared with Hef 
helicases in archaea and the yeast MPH1 helicase. Although FANCM actually shows no helicase 
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activity, it is able to displace the third strand of a triple-helix structure in the presence of ATP, 
suggesting the ability to move along DNA (translocase activity).  
 Two sibling FA patients from an undefined complementation group have mutations in both 
alleles of FANCM8. Attempts to complement fancm mutant cells with FANCM cDNA were 
unsuccessful, perhaps because of inappropriate expression from viral promoters. Each protein in 
the FA core complex (FANCA/B/C/E/F/G/L) is essential for monoubiquitination of FANCD2, a 
critical reaction of unknown biochemical mechanism in the FANC DNA-damage response 
pathway13. FA-M cells also lack FANCD2 monoubiquitination and have impaired nuclear 
localization and defective assembly of other core complex components8.  
 Using chicken cells, Mosedale et al. 9 provide key evidence that FANCM/Hef is essential for 
mediating binding of the core complex to crosslinked DNA within chromatin. Not only do they 
find that a hef mutant disrupted in the helicase domain is essentially epistatic with fancc for 
crosslink sensitivity in a double mutant, they show that the nuclease domain of Hef is largely 
dispensable for resistance to DNA crosslinking.  
   
Assembling the FAscinating puzzle 
 How does the discovery of these two helicase-motif proteins help us understand the repair of 
DNA crosslinks? A recent mechanistic model proposed that the role of FANCD2 
monoubiquitination is to stabilize structurally blocked and broken replication forks, and thereby 
promote both translesion synthesis (TLS) and HR14. In the context of this model, an outline of 
events that may occur during crosslink repair is depicted in Figure 1. Crosslinks are probably 
recognized when they block DNA replication forks. Crosslink “unhooking” requires incision on 
both sides of an adducted base, causing breakage of one parental strand at the replication fork 
(Fig. 1, step B). The ERCC1-XPF endonuclease likely produces one or both incisions15; 
mutations in either protein are known to confer high crosslink sensitivity. One can speculate that 
FANCJ/BRIP1 helicase activity might help create the incision substrate by unwinding the 
parental strands next to the crosslink and/or unwind the short adducted oligonucleotide after 
incision. Restoration of the broken fork requires HR (steps C-E), which involves 
FANCD1/BRCA2 and other proteins that enable Rad51 to perform strand transfer. After 
recombination, another hypothetical role for BRIP1 might be to assist in restarting replication.   
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 Much more FANC protein complexity remains to be elucidated. One reported 
complementation group (FA-I) has not been cloned2. FANCI is also required for FANCD2 
monoubiquitination but, uniquely, does not appear to be a component of the nuclear core 
complex2. Clearly, many additional protein interactions and temporal sequences of events must 
be established to understand crosslink repair. A central question that needs resolution is whether 
the spontaneous chromosomal breakage of FA cells is caused by endogenous crosslinks or 
simply other lesions arising from oxidative base damage. 
 
 
 
 
FIGURE LEGEND 
 
Figure 1  Speculative heuristic model of FA proteins in repairing interstrand crosslinks during 
DNA replication. Upon replication fork arrest/breakage, FANCD2 becomes monoubiquitinated, 
a key event required for resistance to crosslinks. This modification is proposed to promote both 
translesion synthesis (TLS) at blocking adducts and HR to restart broken forks, by architecturally 
stabilizing intermediates14.  
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